KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short-term Investments: 2010-2024

Historic Short-term Investments for Emergent BioSolutions (EBS) over the last 8 years, with Dec 2024 value amounting to $6.1 million.

  • Emergent BioSolutions' Short-term Investments fell 43.08% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 43.08%. This contributed to the annual value of $6.1 million for FY2024, which is N/A change from last year.
  • Emergent BioSolutions' Short-term Investments amounted to $6.1 million in FY2024, which was up 2,950.00% from $200,000 recorded in FY2021.
  • In the past 5 years, Emergent BioSolutions' Short-term Investments ranged from a high of $6.1 million in FY2024 and a low of $200,000 during FY2020.
  • Over the past 1 years, Emergent BioSolutions' median Short-term Investments value was $6.1 million (recorded in 2024), while the average stood at $6.1 million.